Viewing Study NCT07016750


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2025-12-29 @ 12:12 AM
Study NCT ID: NCT07016750
Status: RECRUITING
Last Update Posted: 2025-07-04
First Post: 2025-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis Bullosa
Sponsor: Krystal Biotech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dystrophic Epidermolysis Bullosa View
None DEB - Dystrophic Epidermolysis Bullosa View
None Recessive Dystrophic Epidermolysis Bullosa View
None Dominant Dystrophic Epidermolysis Bullosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dystrophic Epidermolysis Bullosa View
None DEB View
None Corneal Abrasions View